'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow P... (tant administration of food with AMITIZA...)

'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down

Date:11/6/2007

tant administration of food with AMITIZA may reduce symptoms of nausea. Patients who experience severe nausea should inform their physician.

AMITIZA should not be prescribed to patients that have severe diarrhea. Patients should be aware of the possible occurrence of diarrhea during treatment and inform their physician if the diarrhea becomes severe.

In clinical trials, the most common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal pain (8%), abdominal distention (6%), and flatulence (6%).

For full prescribing information, visit http://www.amitiza.com.

AMITIZA(R) is a registered trademark of Sucampo Pharmaceuticals, Inc.

About Chronic Constipation

Constipation is one of the most common digestive complaints, and is the cause of 2.5 million visits to physicians and 92,000 hospitalizations annually. Constipation is defined as unsatisfactory defecation that is characterized by infrequent stools, difficult stool passage or both. Difficult stool passage includes: straining; hard or lumpy stools; difficulty passing stool; incomplete evacuation; prolonged time to stool; or the need for manual maneuvers to pass stool. Symptoms must persist for at least three consecutive months for the condition to be considered chronic.

Sucampo Pharmaceuticals, Inc.

Sucampo Pharmaceuticals, Inc., an emerging pharmaceutical company based in Bethesda, Md., focuses on the development and commercialization of drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. The therapeutic potential of prostones was first identified by Ryuji Ueno, M.D., Ph.D., Ph.D., Sucampo Pharmaceuticals' chairman and chief executive officer. Dr. Ueno founded Sucampo Pharmaceuticals in 1996 with Sachiko Kuno, Ph.D., founding chief executive officer and advisor, international business development. Sucampo Pha
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc. and Sucampo
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
2. ConforMIS Moves Headquarters to Expanded Facilities in Burlington, MA
3. Mediatech Moves to Prince William County Innovation Park
4. FDA Removes Partial Hold on TELCYTA Clinical Development
5. Emisphere Technologies, Inc. Moves Into New Corporate Headquarters
6. BioSpace and BayBio Launch 11th Edition of Biotech Bay(TM) Hotbed Map Campaign
7. BioSpace, 2008 BIO International Convention and BIOCOM Launch 9th Edition of Biotech Beach Hotbed Map Campaign
8. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
9. Homewatch CareGivers Launches 2007 We Care For Veterans Campaign
10. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
11. Nanowire generates power by harvesting energy from the environment

Post Your Comments:

(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, The ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, ... "The Future of Orphan Diseases Therapeutics - ...

(Date:12/15/2009)... WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... ) and the University of Virginia (UVa) ... entered into a strategic research collaboration to ... coronary artery disease (CAD) with a secondary ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The ...

(Date:12/15/2009)... Dec. 15 The Mosaic Company (NYSE: ... year 2010 earnings results and financial tables on Tuesday, ... the New York Stock Exchange. Results will be ... The Company will host a conference call with presentation ... results. The call will begin at 11:00 a.m. ...

(Date:12/15/2009)... Dec. 15 The Center for ... Communications, is pleased to announce the full ... Accounting and Reporting Congress . The forum ... on March 16-17, 2010. ,, Over 1,500 ... have attended this premier event since its ...

[0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress

... Center at TGH to Enhance Clinical Skills,Development, ... a new partnership with the University of South ... for USF Health hospital,partners and for local and ... SimSuite Education Center is located at Tampa,General Hospital, ...

... Oncology Focused Contract Research Organization Exceeds Expectations, ... CRO, a Contract Research,Organization exclusively focused on ... once again exceeded projections as the company ... responded favorably to,ACORN,s ability to consistently exceed ...

... the Amgen Foundation,s ... $27.5 Million Applications for 2009 Amgen ... Nov. 10 Each year, hundreds of,students from across ... under renowned faculty members at the country,s leading,universities. Now, ...

Other Biology Technology:Medical Simulation Corporation Announces Partnership With University of South Florida 2 Medical Simulation Corporation Announces Partnership With University of South Florida 3 ACORN CRO Continues Growth in Strong Third Quarter 2 Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe 2 Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe 3 Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe 4

Medical Simulation Corporation Announces Partnership With University of South Florida ACORN CRO Continues Growth in Strong Third Quarter Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe

(Date:12/15/2009)... 2009 Frost & Sullivan European Border Security ... Securite (Safran Group) for its innovative Automated ... company,s expertise in advanced biometric technology and ... products to end users. ,, (Logo: ... has been involved in delivering identification systems ...

(Date:12/15/2009)... Springer has just signed an agreement with the British ... an affiliation with the journal Biogerontology for ... will appoint one member of the Biogerontology ... issue annually. Springer will sponsor the society and ... Biogerontology on www.springerlink.com . , Biogerontology ...

(Date:12/15/2009)... 2009 - Scientists at VIB and Ghent University in ... treatment of septic shock, the major cause of death ... nitric oxide (NO) gas in mice with septic shock, ... animal,s organs showed much less damage, while their chances ... since it is generally assumed that nitric oxide is ...

Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4 Septic shock: Nitric oxide beneficial after all 2 Winner Medical Announces Two for One Reverse Stock Split 58656 1 Winner Medical Announces Two for One Reverse Stock Split 58656 2 Winner Medical Announces Two for One Reverse Stock Split 58656 3 Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 1 Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 2 Atkins Introduces Six Ways to Shape Up With Tasty 26amp 3B Convenient New Products 58652 3 Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 1 Healthnostics Unveils Biomedical Content Strategy for Medbioworld com 14314 2

[0] Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems [0] Springer signs agreement with British Society of Research on Ageing [0] Septic shock: Nitric oxide beneficial after all

... California Institute of Technology (Caltech) have created a "plug-and-play" ... is capable of taking in and responding to more ... , In the future, such devices could have a ... sensors to sniff out tumor cells or determine when ...

... ,atlas, that pinpoints the location of thousands of individual ... give scientists important insights into the function of different ... could be reflected in diseases such as cancer. Professor ... Stockholm, who is leading the project, said, "We are ...

... quest to discover the root of illnesses, patients have ... that may involve the use of ionising radiation to ... this practice could also put patients at risk. , ... providing the amount of patient protection that medical professionals ...

Other Biology News:Caltech engineers build firast-ever multi-input 'plug-and-play' synthetic RNA device 2 Human protein atlas will help pinpoint disease 2 When the ill need protection from the cure 2 When the ill need protection from the cure 3

Caltech engineers build firast-ever multi-input 'plug-and-play' synthetic RNA device Human protein atlas will help pinpoint disease When the ill need protection from the cure

ImageQuant 300, 1 EA. Category: ImageQuant CCD Imagers....

Recombinant Feline IL-12/IL-23 p40...

RABBIT ANTI ISOCITRATE DEHYDROGENASE...

... Cloning Checker Kits provide two highly efficient ... without time-consuming plasmid preparation. By using the ... you need to do is to transfer ... from the transformation plates into the solutions ...

Biology Products:

ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems Rabbit Anti-ISOCITRATE DEHYDROGENASE Polyclonal Antibody, Unconjugated from AbD Serotec Express Cloning Checker Kit I from BioChain

'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow P...(tant administration of food with AMITIZA...)